Clinical Outcomes and Perinatal Results in Pregnant Patients with Systemic Lupus Erythematosus in the Intensive Care Unit
Juan Gustavo Vázquez Rodríguez, Karime Soledad Ortiz Ambrosio, Juan Gustavo Vázquez Arredondo
International Journal of Research and Reports in Gynaecology · pp. 40–47 · Published 3 Mar 2025
10.9734/ijrrgy/2025/v8i1116Abstract
Aim: To identify the clinical outcomes and perinatal results in patients with SLE (Systemic Lupus Erythematosus) managed in the intensive care unit (ICU). Study Design: Retrospective, observational and descriptive study. Place and Duration of Study: ICU of the High Specialty Medical Unit of Gynecology and Obstetrics Hospital No. 3, National Medical Center “La Raza” belonging to the Mexican Institute of Social Security in Mexico City, between January 1, 2017 and July 31, 2024. Methodology: A retrospective, observational and descriptive study was carried out in a cohort of 41 pregnant patients with SLE admitted to the ICU in the years 2017 to 2024. The records were consulted to know their general data, clinical outcomes and perinatal results. For data analysis, descriptive statistical measures were used with the statistical program SPSS™ version 22.0. Results: ICU admission data: maternal age 28.1±5.30 years, pregnancy 28±8 weeks. Time of SLE diagnosis 6.16±4.87 years. Reasons for ICU admission: preeclampsia-eclampsia 36.56%, uncontrolled chronic hypertension 29.26% and lupus activity 12.19%. Antihypertensive agents were required in 80.48%, vasoactive amines in 4.87%, cardiotonic agents 2.43%, antiarrhythmic drugs 2.43%, transfusion therapy 46.34%, and mechanical ventilatory support 19.51%. Mode of termination of pregnancy: cesarean section 67.50%, instrumented uterine curettage 17.50%, vaginal delivery 10% and hysterotomy 5%. Complications: postpartum hemorrhage 15%, incidental injury to an iliac vein 5%, surgical reintervention 5%, choriamnioitis 2.5%, intestinal laceration 2.5%% and unpacking 2.5%. ICU stay 3.43±2.66 days. Prolonged stay in the ICU (>8 days) was found in 7.31%. Maternal mortality 0%. Preterm products 76.92%, and term products 23.08%, survival 63.41%, overall fetal mortality 36.59% (abortion 19.51%, utero death 4.87%, and perinatal death 12.19%). Conclusion: The maternal clinical outcomes was satisfactory. Perinatal results were unfavorable with high rates of prematurity, abortion, in utero death, and perinatal death.
Cited by 0
No indexed citations yet.
Related research
- Comparative Study of Fetomaternal Outcome in Abruptio Placenta and Placenta Previa — shares topic coverage
- Outcome of Management of Pregnant Women with Decreased Fetal Movements in a Resource Constrained Setting in Southwest Nigeria — shares topic coverage
- Perinatal Outcomes and Determinants among Hypertensive Pregnant Women in Hyderabad: A Retrospective Analysis — shares topic coverage
- Impact of Anemia during Pregnancy on Maternal and Perinatal Outcomes — shares topic coverage
- Relationship between the Gestational Age at Delivery, Obstetric Parameters and Perinatal Outcomes in the University of UYO Teaching Hospital — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.